Surfix

Over Surfix

Surfix is redefining point-of-care diagnostics with an innovative Photonic Diagnostic Platform; a multi-modal solution that combines superior precision for protein detection over current lab-testing platforms with the speed and simplicity of point-of-care testing. As a rapidly growing startup, our focus is on strategic partnerships for co-developing immunoassays with diagnostic, biomarker discovery, and biopharmaceutical companies and then expanding our platform to include molecular and combined capabilities.

The core of Surfix’s photonic diagnostics platform is a photonic biosensor consisting of a photonic biochip and a microfluidic cartridge both optimized with Surfix's proprietary nanocoatings. The biosensor is used in combination with a dedicated desktop reader.

Trefwoorden

• Antifouling/Anti-Sticking
• Biofunctionalization
• Cancer
• Chemical Selective Modification
• Diagnostics
• Early Detection
• Immunoassays
• Lab-On-A-Chip
• Liquid Biopsy
• Local (Channel) Modification
• Microfluidics
• Photonic Biochip
• Point-Of-Care
• Reproducibility

Adres

• Hoofdkantoor

  Agro Business Park 26708PW WageningenGelderland, Nederland

Team per functiegebied

Gebaseerd op 34 openbare functieprofielen, stand van 2 september 2026.

• Research / R&D12
• Engineering / Software Development9
• Executive / C-Suite8
• Operations3
• Finance / Accounting1
• HR / People / Recruiting1